Scarica l'app Stockscreener
68.08
0.44%
0.30
Dopo l'orario di chiusura:
68.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$67.78
Aprire:
$67.56
Volume 24 ore:
3.32M
Relative Volume:
0.71
Capitalizzazione di mercato:
$26.70B
Reddito:
$4.30B
Utile/perdita netta:
$571.50M
Rapporto P/E:
47.66
EPS:
1.4285
Flusso di cassa netto:
$570.80M
1 W Prestazione:
+2.47%
1M Prestazione:
-13.16%
6M Prestazione:
+1.86%
1 anno Prestazione:
-2.21%
Intervallo 1D:
$67.24
$69.00
Intervallo di 1 settimana:
$64.90
$69.00
Portata 52W:
$57.52
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Nome
Dexcom Inc
Settore
Industria
Telefono
(858) 200-0200
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Confronta DXCM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
68.08 | 26.58B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
133.31 | 233.69B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.28 | 143.42B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.20 | 143.48B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.50 | 125.54B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.19 | 44.47B | 5.69B | 1.41B | 577.90M | 6.9828 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-08-21 | Iniziato | Argus | Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-02-03 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Iniziato | Redburn Atlantic | Neutral |
| 2024-03-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-01-26 | Iniziato | Wolfe Research | Outperform |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-15 | Iniziato | Bernstein | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-18 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2021-01-06 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Reiterato | Piper Sandler | Overweight |
| 2020-05-14 | Iniziato | Wells Fargo | Equal Weight |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-11-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-10-23 | Iniziato | Stifel | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-09-12 | Aggiornamento | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Reiterato | Canaccord Genuity | Buy |
| 2018-07-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
| 2018-05-03 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-04 | Iniziato | Goldman | Sell |
| 2018-04-04 | Iniziato | Guggenheim | Neutral |
| 2018-03-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Downgrade | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Reiterato | Wedbush | Outperform |
Mostra tutto
Dexcom Inc Borsa (DXCM) Ultime notizie
Real time scanner hits for DexCom Inc. explainedTrade Risk Report & AI Based Buy and Sell Signals - newser.com
Will DexCom Inc. benefit from macro trendsWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
DexCom Inc. stock trend forecast2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
Is it too late to sell DexCom Inc.2025 Investor Takeaways & Target Return Focused Picks - newser.com
Is DexCom Inc. (DC4) stock resilient in recession scenarios2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Can DexCom Inc. stock deliver sustainable ROEWeekly Stock Report & Low Drawdown Investment Strategies - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc.DXCM - PR Newswire
DexCom Inc Stock Analysis and ForecastIPO Market Watch & Exceptional Capital Trading - earlytimes.in
Shell Asset Management Co. Buys 5,138 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Stake Raised by DAVENPORT & Co LLC - MarketBeat
Janney Montgomery Scott LLC Trims Stake in DexCom, Inc. $DXCM - MarketBeat
William Blair Maintains Bullish Stance on DexCom (DXCM) Stock - Yahoo
Citigroup Issues Pessimistic Forecast for DexCom (NASDAQ:DXCM) Stock Price - MarketBeat
DexCom (DXCM): Citigroup Lowers Price Target, Maintains "Buy" Ra - GuruFocus
What analysts say about DexCom Inc DC4 stockSector Performance Drivers & Diversify Intelligently to Avoid Big Hits - earlytimes.in
Applying big data sentiment scoring on DexCom Inc.Trend Reversal & Entry and Exit Point Strategies - newser.com
Comprehensive Financial Consultants Institutional Inc. Grows Position in DexCom, Inc. $DXCM - MarketBeat
Can DexCom Inc. (DC4) stock deliver consistent EPS growthWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
DexCom May Be The Most Underrated Growth Story In Healthcare (NASDAQ:DXCM) - Seeking Alpha
What dividend safety rating applies to DexCom Inc. (DC4) stockEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
DexCom, Inc. $DXCM Shares Purchased by Sendero Wealth Management LLC - MarketBeat
Combining price and volume data for DexCom Inc.July 2025 Fed Impact & Daily Growth Stock Tips - newser.com
DexCom (DXCM): Valuation Insights as G7 Reliability Improves and Reimbursement Expands - Sahm
DexCom, Inc. Reports Second Quarter 2017 Financial Results - ADVFN
Published on: 2025-10-05 05:15:42 - newser.com
Is DexCom Inc. stock entering bullish territoryWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Mirae Asset Global Investments Co. Ltd. Has $16.65 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
Robeco Institutional Asset Management B.V. Sells 31,727 Shares of DexCom, Inc. $DXCM - MarketBeat
Can DexCom Inc. (DC4) stock sustain double digit ROE2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Why Analysts See DexCom’s Outlook Shifting Amid New Leadership and Changing Growth Drivers - Yahoo Finance
Franklin Street Advisors Inc. NC Makes New $686,000 Investment in DexCom, Inc. $DXCM - MarketBeat
DexCom Stock Price, Quotes and Forecasts | NASDAQ:DXCM - Benzinga
What MACD trends signal for DexCom Inc. (DC4) stockBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com
How to escape a deep drawdown in DexCom Inc.Quarterly Profit Report & AI Powered Market Entry Ideas - newser.com
DexCom, Inc. $DXCM Shares Acquired by J. Safra Sarasin Holding AG - MarketBeat
Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time. - BioSpace
Why DexCom Inc. stock remains on watchlistsBond Market & Real-Time Stock Movement Alerts - newser.com
North America Precision Nutrition Market Analysis Report 2025-2032: Abbott, Dexcom, Nestle and DSM Lead Ecosystem Expansion with Integrated Diagnostics and Supplements - Yahoo Finance
Lecap Asset Management Ltd. Has $1.88 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Holdings Decreased by Greenleaf Trust - MarketBeat
DexCom (NASDAQ:DXCM) Given New $89.00 Price Target at The Goldman Sachs Group - Defense World
DexCom (NASDAQ:DXCM) Trading Down 4.9% on Analyst Downgrade - Defense World
Goldman Sachs Maintains DexCom (DXCM) Buy Recommendation - Nasdaq
TD Cowen Maintains its Buy Rating and $100 PT for DexCom, Inc. (DXCM) - Insider Monkey
DEXCOM SHAREHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
DexCom (NASDAQ:DXCM) Trading Down 4.9% After Analyst Downgrade - MarketBeat
Dexcom Inc Azioni (DXCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.78%
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):